Utomilumab (Synonyms: PF 05082566) |
| Catalog No.GC70104 |
Utomilumab (PF 05082566)은 인간 유래의 IgG2 mAb 활성제로, T 세포 공동 자극 수용체 4-1BB/CD137을 타겟으로 합니다. Utomilumab은 재발/치료 어려운 만성림프구종 (FL) 및 기타 CD20+ 비호지킨 림프종(NHL) 연구에 사용될 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1417318-27-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Utomilumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Utomilumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *